I don't think the short exit is mainly going to do it... not often a billion dollar startup has a binary yes will be successful or not outcome. I think the buying pressure from everyone else will far outweigh the shorts. Not many other.. infact no other biotech on ASX with the phase 3 opportunity pool msb has.
Remember as Reg says, first cab off the ramp will be expansion into adult trial, which is a 6 - 9x market value than pediatric.
Concurrently the CLBP has over 1,000 times the number of patients alone, than pediatric sr gvhd, and MSB have been busy updating their bioreactor , bovine free serum patents. The yields are better than with FBS according to the patent.
Approval means rapid pathway to greatness.
- Forums
- ASX - By Stock
- 2023 The Final Countdown
I don't think the short exit is mainly going to do it... not...
-
- There are more pages in this discussion • 647 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
|
|||||
Last
97.0¢ |
Change
-0.005(0.51%) |
Mkt cap ! $1.107B |
Open | High | Low | Value | Volume |
98.5¢ | 98.5¢ | 96.0¢ | $2.168M | 2.226M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 16000 | 96.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.0¢ | 86854 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 16000 | 0.965 |
1 | 23000 | 0.960 |
4 | 56273 | 0.955 |
5 | 46225 | 0.950 |
2 | 65500 | 0.945 |
Price($) | Vol. | No. |
---|---|---|
0.970 | 50000 | 2 |
0.975 | 20000 | 1 |
0.980 | 894 | 1 |
0.985 | 48122 | 2 |
0.990 | 54328 | 5 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
MSB (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online